📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BYDDF.
💹 Market Data
Market Cap$105.21B
Shares Outstanding3.68B
FloatN/A
Cash$19.14B
Debt$21.33B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 48.3% shares (2025Q4 vs prior)
21 institutional holders · 326.3K shares
#1
Generali Investments CEE, investicni spolecnost, a.s.
78.8K shares
#2
Runnymede Capital Advisors, Inc.
53.8K shares
#3
Trivant Custom Portfolio Group, LLC
53.8K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest14.16M
Days to Cover45.0
% of FloatN/A
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for BYDDF
📊 BYDDF FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BYDDF Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.